HIGHLIGHTS
- who: Giuseppe Roberto and collaborators from the ETH Zu00fcrich, Switzerland Maastricht University Medical Centre have published the research work: Time to Treatment Intensi cation in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, in the Journal: (JOURNAL) of 30/06/2015
- what: The aim of this study was to analyse routinely collected administrative data from four Italian geographic areas to verify whether, among patients on metformin (MET) monotherapy for T2D, the add-on of a DPP4i compared to SU was associated with a delay in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.